Literature DB >> 6733070

Evaluation of the Friedmann Visual Field Analyser Mark II. Part 2. Results from a population with induced visual field defects.

D B Henson, S M Dix.   

Abstract

The Friedmann Visual Field Analyser Mark II is evaluated with a group of 301 normal eyes, 155 of which had an induced visual field defect. Measures of sensitivity and specificity are calculated from these data by criteria similar to those used by other researchers. The inadequacies of using pass/fail criteria in the clinical situation are discussed, and a solution is proposed in which each field response is scored and the score compared with those from normal and defective populations. An example is given of how this form of analysis could be incorporated into the clinical situation.

Entities:  

Mesh:

Year:  1984        PMID: 6733070      PMCID: PMC1040382          DOI: 10.1136/bjo.68.7.463

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Dethecting glaucomatous damage with the Friedmann analyzer compared with te Goldmann perimeter and evaluation of stereoscopic photographs of the optic disk.

Authors:  K A Batko; J L Anctil; D R Anderson
Journal:  Am J Ophthalmol       Date:  1983-04       Impact factor: 5.258

2.  Comparative evaluation of the Autofield-I, CFA-120, and Fieldmaster Model 101-PR automated perimeters.

Authors:  C A Johnson; J L Keltner
Journal:  Ophthalmology       Date:  1980-08       Impact factor: 12.079

3.  The glaucomatous visual field.

Authors:  S M Drance
Journal:  Invest Ophthalmol       Date:  1972-02

4.  Performance of computer assisted perimeters.

Authors:  E L Greve
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

  4 in total
  1 in total

1.  Evaluation of the Friedmann Visual Field Analyser Mark II. Part 1. Results from a normal population.

Authors:  D B Henson; S M Dix; A C Oborne
Journal:  Br J Ophthalmol       Date:  1984-07       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.